Haihua Yuan clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-22
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.
- Notable: Trastuzumab Rezetecan · HER2-Expressiong Advanced Solid Tumor Recruitment opened
- Notable: Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy Recruitment opened
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 2 | 2 |
Disease areas by active trials, top 10 of 12
Bladder Cancer (2) · Cervical Cancer (2) · Colorectal Cancer (2) · Endometrial Cancer (2) · Head & Neck Cancer (2) · Pancreatic Cancer (2) · Cholangiocarcinoma (1) · Gastric Cancer (1) · HER2-Positive Cancer (1) · Lung Cancer (1)
Get alerts when Haihua Yuan's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.